That's crucial, due to the fact that the method a protein in the body folds figures out if a pharmaceutical will have the ability to bind to that protein and be reliable. Simply put, we have to understand how these proteins fold if we want a drug to work. Historically, this has been an experimental procedure (what is the legacy report predicting). Today, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it a lot easier to develop drugs that do what they're developed to do. This was a breakthrough almost nobody discovered. However it's going to have extensive implications for curing illness. I forecast that Alpha, Fold will be 98% accurate by the end of 2021.
And, obviously, there will be plenty of investment opportunities in this space, too. Shifting subjects It's going to be a great year for bitcoin. I'm bullish on it in 2021 (jeff brown investment prediction). That stated, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be shocked if it drew back maybe substantially before going higher - angel investor. I've been covering bitcoin for a very long time now. One of the very first research study reports I ever released was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial recommendation, I entitled my report "What's the Big Offer With Bitcoin?" That shows you where the discussion was at the time. We were primarily educating readers. However that's not the huge concern anymore. Now we're seeing institutional money finally take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, specific niche business. Mass, Mutual is a relied on 170-year-old organization. So think of that. In five years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a huge reason I'm bullish on it this year. jeff brown predictions for 2021. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus forecast 2020 was a record year for IPOs. 552 U.S. business went public the most in more than 20 years. These business raised an overall of $172 billion. That's an all-time high beating the previous yearly record by 43%. I anticipate 2021 will be another record year in IPOs. There are so many great private business on the verge of hitting the public markets And I've been dealing with a new method for you to invest even before these business go public.
This opportunity has actually been building over the last couple of years. I can't wait to tell you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to find out all the information. Go right here to book your spot free of charge.
Emma Walsh here, managing editor of the Journal. Routine Diary readers know that tech isn't our usual beat (jeff brown 1 biotech company). And when it pertains to tech investing, we leave it to the experts. Luckily, we have a number of such professionals in our Rolodex. Our colleague Jeff Brown will recognize to our longtime readers. He is among the most accomplished tech investing experts we understand (tech stocks). In truth, he had numerous triple-digit returns in his Brownstone Research portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take a look at the huge picture and forecast what's simply around the corner.
That consists of things like 5G networks, biotech, expert system, and far more. These patterns are experiencing exponential growth and creating extraordinary opportunities for investors. I want to make sure all our readers are prepared for what's next. And with that in mind, let me draw the photo of what I see can be found in the next 12 months Our new 5G (fifth-generation) cordless networks are a subject I've been covering for years now. jeff brown top biotech stock 2021. However regardless of what lots of readers may think, this is a pattern that's just starting. Although the COVID-19 pandemic interfered with supply chains last year, an excellent 250 million 5G-enabled devices were still sold.
And all of this eventually caused Apple delaying the release of the 5G-enabled i, Phone 12 by two months (jeff brown biotech stock). Losing two months of production and sales actually impacts how many 5G devices are offered in the calendar year. When you consider all of that, selling 250 million systems is impressive. More importantly, the hold-ups triggered by the pandemic developed a lots of suppressed demand. And that demand is now going to be pushed into 2021. In truth, I anticipate that more than 500 million 5G gadgets will be delivered in 2021 - jeff brown biotech picks. And that's not my only 5G forecast When I have actually discussed 5G in the past, I have actually explained its 3 different phases.
In Stage Two, 5G gadgets go on sale. 5G phones and other products start to reach consumers. And in Stage Three, 5G services start to be provided (jeff brown prediction). That's when we begin to see applications running on 5G networks. Think about things like massive multiplayer video games over a cellphone. That's not possible with 4G. It will be with 5G. And my second 5G prediction for 2021 is that we will start Phase Three by this summertime. This begins something of a virtuous cycle: Many people do not actually care about the innovation. However they will care if there are amazing applications that can only be accessed with a 5G phone.
That results in more 5G apps being established. In reality, 5G is going to open up a suite of extraordinary applications: self-driving automobiles, the Internet of Things, robotic surgical treatment, and more. All of these technologies require 5G. The investment opportunities moving forward will be enormous. Stepping far from 5G, the next essential technology I anticipate in 2021 is CRISPR hereditary modifying. CRISPR means "clustered frequently interspaced brief palindromic repeat." It's a mouthful. But it's one of the most interesting advancements in biotechnology. At a high level, CRISPR is an innovation that can edit our genetic makeup as if it were software application.
The program can crash or not work properly. CRISPR uses a comparable idea but with our hereditary code. "Typos" in our genome can cause disease. CRISPR can correct these "typos." For years, CRISPR was primarily a specific niche innovation that wasn't well comprehended. And throughout that time, there were truly only 3 companies operating in this space. But things are changing. CRISPR is no longer simply theoretical. We're seeing real outcomes. We're dealing with diseases and seeing that this innovation simply works. And as a result, a "2nd crop" of early-stage CRISPR business is going public and providing unbelievable returns. This whole market is efficiently a greenfield chance.
There's space for numerous business to exist in this space. jeff brown top biotech 2020. And there will be more. That's my forecast for CRISPR in 2021. I predict that 2 or three more genetic modifying companies will hold their IPOs. Sticking with biotechnology, we are seeing amazing things occurring at the convergence of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, simply announced at the end of 2020 that its latest Alpha, Fold software application can properly anticipate the folding of a protein based solely on its amino acid sequence with 92. 4% accuracy. That is very important due to the fact that the method a protein in the human body folds identifies if a pharmaceutical will have the ability to bind to that protein and work.
Historically, this has been a trial-and-error procedure. However now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it much simpler to produce drugs that do what they're developed to do. And here's my next prediction. I forecast that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one but several drug treatments produced utilizing this technology. This was one of those advancements that nearly no one noticed. However it's going to have extensive ramifications for curing illness. And, naturally, there will be a lot of investment opportunities in this area, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be volatile. We're close to all-time highs. I would not be surprised if it drew back maybe significantly prior to going higher. I have actually been covering bitcoin for a very long time now. Among the very first research reports I ever published was on bitcoin - jeff brown investment prediction. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for anybody who followed my recommendation. But at the time of that initial suggestion, I titled my report, "What's the Big Deal With Bitcoin?" That shows you where the conversation was at the time.
However no one is asking that concern any longer. Now, we're seeing institutional money lastly taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche business. longtime readers. Mass, Mutual is a 150-year-old organization. So consider that. In 5 years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more benefit forecast In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown deserves about $27. 5 million and declares the details depends on date since February 2021, however we could not individually verify this claim. Offered Jeff Brown's past, he likely has a considerable net worth, but we can't hammer down an accurate figure at this minute. Brown is best known for his sage-like capability to pick winning innovation stocks. He invested more than 25 years investigating innovation business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience provides him an outstanding viewpoint on the marketplace. He's always on the hunt for brand-new chances, and he shares a number of his best picks in the Future Report.
That's full marks, however it's not absurdly reasoned. Brown has an outstanding track record as a stock-picker, and he successfully forecasted a few of the greatest economic events of the past 20 years. Although he doesn't appear to release his choices to the public, the service's success is a direct indication of Brown's stock-picking prowess. Nobody on Wall Street gets it right each time, however Jeff Brown's accurate predictions have actually made him legions of dedicated fans. That states a lot about his capability. The Near Future Report is released by Brownstone Research study, a popular monetary research publisher. Brownstone Research study provides numerous research study services with a wide array of specializations - jeff bezos.
The company is also associated with Bonner & Partners, another well-respected research publisher - biotech stocks. On its website, Brownstone states its mission is to supply retail financiers with professional-grade research study: "For too long, the very best financial investment research study has actually not been readily available to private investors. It has been normally scheduled for financial investment banks, hedge funds, private equity, and high-net-worth clients. future report review. The mission of Brownstone Research study is to make that kind of proprietary research readily available to any financiers wanting to acquire an edge in the markets. The objective is simple to provide special and lucrative financial investment research discovered nowhere else." -Brownstone Research site excerpt from the Jeff Brown is the creator of Brownstone Research, and he also works as the company's Chief Investment Analyst.
With Brown directing the ship, Brownstone Research study is a powerhouse publisher with lots to use its customers. After years of consistent success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a family name throughout the majority of America. If you know even a little bit about the marketplace, you know that he has a credibility as a King Midas of sorts. jeff brown stock market prediction. Everything he touches turns to gold! Jeff is aware of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge project.
In fact, Brown thinks S.A.V. white house. might be "the most significant pattern of the 2020s, and he's not alone. Have a look at these quotes from other well-known S.A.V. bulls: Elon's next big act will be marrying 2 cutting-edge innovations: expert system and electrical automobiles. Musk hopes the mix will assist him develop the first fully-autonomous, self-driving automobiles ever. It's absolutely nothing except the vehicle industry's Holy Grail. As you understand, electric vehicles and self-driving vehicle stocks have actually been big this year, however the Wall Street machine has been big on hype without much concrete outcome. Despite an extreme boost in competition over the previous few years, Brown still thinks Musk has the best possibility of putting everything together.
tech might be the magic string that ties everything together. S.A.V. means Shared Autonomous Vehicle, and it could be the future of transport. Generally, this innovation would permit you to rent your cars and truck as an autonomous, self-driving taxi when you're not utilizing it. You simply leave the automobile and press a button on an app that tells the cars and truck to "sign up with the fleet." Next thing you know, you're relaxing on your sofa while your vehicle shuttles ride-sharers around town. Best of all, you get to keep a large portion of the earnings. It sounds outrageous, but it might be closed than you think.